[an error occurred while processing this directive]
综述

血液透析患者中必需微量元素的益处和风险

  • 胡睿 ,
  • 刘岩 ,
  • 刘云
展开
  • 550004 贵阳,1贵州医科大学临床医学院
    510220 广州,2暨南大学附属广州红十字会医院肾内科 营养研究所

收稿日期: 2024-03-12

  修回日期: 2024-03-27

  网络出版日期: 2024-06-12

The benefits and risks of essential trace elements in hemodialysis patients

  • HU Rui ,
  • LIU Yan ,
  • LIU Yun
Expand
  • Clinical Collage of Medicine, Guizhou Medical University, Guiy ang 550004, China; 2Department of Nephrology, Institute of Disease-Oriented Nutritional Research, Guangzhou Red Cross Hospital, Jinan University, Guangzhou 510220, China

Received date: 2024-03-12

  Revised date: 2024-03-27

  Online published: 2024-06-12

摘要

肾脏是人体微量元素代谢的重要器官,对于终末期肾病(end-stage renal disease,ESRD)患者,因为食物摄入的减少、肠道吸收功能的改变、肾脏排泄功能的下降以及肾衰竭所致体内代谢的改变,会导致体内全血、血清或血浆微量元素发生改变。同时,由于透析清除和透析液水质量存在差异,对于接受血液透析(hemodialysis,HD)治疗的患者,在之前的基础上,体内微量元素更容易出现缺乏和过量的风险,并与HD患者的多种并发症以及住院、死亡风险相关。因此,对HD患者微量元素的研究具有重要的临床意义。

本文引用格式

胡睿 , 刘岩 , 刘云 . 血液透析患者中必需微量元素的益处和风险[J]. 中国血液净化, 2024 , 23(06) : 445 -448 . DOI: 10.3969/j.issn.1671-4091.2024.06.010

Abstract

Kidney is an important organ for metabolism of trace elements in human body. In end-stage renal disease (ESRD) patients, changes in trace element levels in whole blood, serum or plasma may occur due to reduced food intake, abnormal function of intestinal absorption, decreased renal excretion capacity, and metabolic alterations resulting from renal failure. Additionally, hemodialysis patients face an even greater risk of trace element deficiency or excess due to the differences in dialysis clearance and quality of dialysis water. The abnormal metabolism of trace elements is associated with risks of various complications, hospitalization and mortality among hemodialysis patients. Therefore, the study of trace elements in hemodialysis patients is of clinical importance. 

参考文献

[1]FOREMAN K J, MARQUEZ N, DOLGERT A, et al.Forecasting life expectancy,years of life lost,and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories[J].Lancet, 2018, 392(10159):2052-90 [2]KALANTAR-ZADEH K, JAFAR T H, NITSCH D, et al.Chronic kidney disease[J].Lancet, 2021, 398(10302):786-802 [3]AMMIRATI A L.Chronic Kidney Disease[J].Rev Assoc Med Bras, 2020, 66Suppl 1(Suppl 1):s03-s9 [4]LOCATELLI F, FOUQUE D, HEIMBURGER O, et al.Nutritional status in dialysis patients: a European consensus[J].Nephrol Dial Transplant, 2002, 17(4):563-72 [5]STOJSAVLJEVI? A, RISTI?-MEDI? D, KRSTI? ?, et al.Circulatory Imbalance of Essential and Toxic Trace Elements in Pre-dialysis and Hemodialysis Patients[J].Biol Trace Elem Res, 2022, 200(7):3117-25 [6]TONELLI M, WIEBE N, HEMMELGARN B, et al.Trace elements in hemodialysis patients: a systematic review and meta-analysis [J].BMC Med, 2009, 1741(7015):7-25 [7]KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update.Executive summary[J].Am J Kidney Dis, 2009, 53(3 Suppl 2):S11-104 [8]BARCELOUX D G.Copper[J].J Toxicol Clin Toxicol, 1999, 37(2):217-30 [9]DE ROMA?A D L, OLIVARES M, UAUY R, et al.Risks and benefits of copper in light of new insights of copper homeostasis[J].J Trace Elem Med Biol, 2011, 25(1):3-13 [10]PRODANCHUK M, MAKAROV O, PISAREV E, et al.Disturbances of trace element metabolism in ESRD patients receiving hemodialysis and hemodiafiltration[J].Cent European J Urol, 2014, 66(4):472-6 [11]ALMEIDA A, GAJEWSKA K, DURO M, et al.Trace element imbalances in patients undergoing chronic hemodialysis therapy - Report of an observational study in a cohort of Portuguese patients[J].J Trace Elem Med Biol, 2020, 62(12):65-80 [12]AZEVEDO R, GENNARO D, DURO M, et al.Further Evidence on Trace Element Imbalances in Haemodialysis Patients-Paired Analysis of Blood and Serum Samples[J].Nutrients, 2023, 15(8):12-19 [13]JOMOVA K, VALKO M.Advances in metal-induced oxidative stress and human disease[J].Toxicology, 2011, 283(2-3):65-87 [14]ZHANG Z, DALAN R, HU Z, et al.Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease[J].Adv Mater, 2022, 34(35):21-69 [15]MURPHY E, LIU J C.Mitochondrial calcium and reactive oxygen species in cardiovascular disease[J].Cardiovasc Res, 2023, 119(5):1105-16 [16]OKUYAMA S, MISHINA H, HASEGAWA K, et al.Probable atherogenic role of zinc and copper as studied in chronic hemodialysis patients[J].Tohoku J Exp Med, 1982, 138(2):227-9 [17]TONELLI M, WIEBE N, BELLO A, et al.Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study[J].Clin J Am Soc Nephrol, 2018, 13(6):907-15 [18]LIU Y, WANG L, LI S, et al.Associations Between Blood Trace Element Levels and Nutritional Status in Maintenance Hemodialysis[J].J Ren Nutr, 2021, 31(6):661-8 [19]CHEN J, JIANG Y, SHI H, et al.The molecular mechanisms of copper metabolism and its roles in human diseases[J].Pflugers Arch, 2020, 472(10):1415-29 [20]LóPEZ MELERO E, RUíZ-ROSO G, BOTELLA I, et al.Pancytopenia due to copper deficiency in a hemodialysis patient[J].Nefrologia (Engl Ed), 2019, 39(4):451-2 [21]MACDONALD R S.The role of zinc in growth and cell proliferation[J].J Nutr, 2000, 130(5S Suppl):1500-s [22]ROOHANI N, HURRELL R, KELISHADI R, et al.Zinc and its importance for human health: An integrative review[J].J Res Med Sci, 2013, 18(2):144-57 [23]SHI Y, ZOU Y, SHEN Z, et al.Trace Elements, PPARs, and Metabolic Syndrome [J]. Int J Mol Sci, 2020, 21(7):12-26 [24]VOELKL J, TUFFAHA R, LUONG T T D, et al.Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB[J].J Am Soc Nephrol, 2018, 29(6):1636-48 [25]JAROSZ M, OLBERT M, WYSZOGRODZKA G, et al.Antioxidant and anti-inflammatory effects of zincZinc-dependent NF-κB signaling[J].Inflammopharmacology, 2017, 25(1):11-24 [26]HE F, RU X, WEN T.NRF2, a Transcription Factor for Stress Response and Beyond[J].Int J Mol Sci, 2020, 21(13):47-77 [27]CHOI S, LIU X, PAN Z.Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases[J].Acta Pharmacol Sin, 2018, 39(7):1120-32 [28]BRAUN L A, ROSENFELDT F.Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy[J].Int J Clin Pract, 2013, 67(8):717-25 [29]CHEN Y H, JENG S S, HSU Y C, et al.In anemia zinc is recruited from bone and plasma to produce new red blood cells [J].J Inorg Biochem, 2020, 210(11):11-72 [30]ELGENIDY A, AMIN M A, AWAD A K, et al.Serum Zinc Levels in Chronic Kidney Disease Patients,Hemodialysis Patients,and Healthy Controls: Systematic Review and Meta-Analysis[J].J Ren Nutr, 2023, 33(1):103-15 [31]ANGUITA E, HUGHES J, HEYWORTH C, et al.Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2[J].Embo j, 2004, 23(14):2841-52 [32]FENG H L, CHEN Y H, JENG S S.Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin [J].Int J Mol Sci, 2019, 20(20):49-85 [33]RAYMAN M P.The importance of selenium to human health[J].Lancet, 2000, 356(9225):233-41 [34]FLORES-MATEO G, NAVAS-ACIEN A, PASTOR-BARRIUSO R, et al.Selenium and coronary heart disease: a meta-analysis[J].Am J Clin Nutr, 2006, 84(4):762-73 [35]HOFFMANN P R, BERRY M J.The influence of selenium on immune responses[J].Mol Nutr Food Res, 2008, 52(11):1273-80 [36]BLEYS J, NAVAS-ACIEN A, GUALLAR E.Serum selenium levels and all-cause,cancer,and cardiovascular mortality among US adults[J].Arch Intern Med, 2008, 168(4):404-10 [37]EATON C B, ABDUL BAKI A R, WARING M E, et al.The association of low selenium and renal insufficiency with coronary heart disease and all-cause mortality: NHANES III follow-up study[J].Atherosclerosis, 2010, 212(2):689-94 [38]ZACHARA B A, GROMADZI?SKA J, WASOWICZ W, et al.Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review[J].Acta Biochim Pol, 2006, 53(4):663-77 [39]ZACHARA B A, SALAK A, KOTERSKA D, et al.Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure[J].J Trace Elem Med Biol, 2004, 17(4):291-9 [40]FUJISHIMA Y, OHSAWA M, ITAI K, et al.Serum selenium levels in hemodialysis patients are significantly lower than those in healthy controls[J].Blood Purif, 2011, 32(1):43-7 [41]FUJISHIMA Y, OHSAWA M, ITAI K, et al.Serum selenium levels are inversely associated with death risk among hemodialysis patients[J].Nephrol Dial Transplant, 2011, 26(10):3331-8 [42]ZHU D, ZHONG Q, LIN T, et al.Higher serum selenium concentration is associated with lower risk of all-cause and cardiovascular mortality among individuals with chronic kidney disease: A population-based cohort study of NHANES .[J]. Front Nut, 2023, 10(112):71-88 [43]LIU M L, XU G, HUANG Z Y, et al.Euthyroid sick syndrome and nutritional status are correlated with hyposelenemia in hemodialysis patients[J].Int J Artif Organs, 2011, 34(7):577-83 [44]XU S, ZOU D, TANG R, et al.Levels of trace blood elements associated with severe sleep disturbance in maintenance hemodialysis patients[J].Sleep Breath, 2021, 25(4):2007-13 [45]YASUKAWA M, ARAI S, NAGURA M, et al.Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients[J].Kidney Int Rep, 2022, 7(7):1565-74 [46]ZACHARA B A, GROMADZINSKA J, PALUS J, et al.The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study[J].Biol Trace Elem Res, 2011, 142(3):274-83 [47]SALEHI M, SOHRABI Z, EKRAMZADEH M, et al.Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized,double-blind,placebo-controlled trial[J].Nephrol Dial Transplant, 2013, 28(3):716-23 [48]ZUMBRENNEN-BULLOUGH K, BABITT J L.The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients[J].Nephrol Dial Transplant, 2014, 29(2):263-73 [49]NAIRZ M, WEISS G.Iron in infection and immunity.[J]. Mol Aspects Med,, 2020, 75(10):8-64 [50]NAKANISHI T, KURAGANO T, NANAMI M, et al.Iron Localization and Infectious Disease in Chronic Kidney Disease Patients[J].Am J Nephrol, 2016, 43(4):237-44 [51]SONNWEBER T, THEURL I, SEIFERT M, et al.Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients[J].Nephrol Dial Transplant, 2011, 26(3):977-87 [52]HOEN B, KESSLER M, HESTIN D, et al.Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey[J].Nephrol Dial Transplant, 1995, 10(3):377-81 [53]KURAGANO T, MATSUMURA O, MATSUDA A, et al.Association between hemoglobin variability,serum ferritin levels,and adverse eventsmortality in maintenance hemodialysis patients[J].Kidney Int, 2014, 86(4):845-54 [54]PARKKINEN J, VON BONSDORFF L, PELTONEN S, et al.Catalytically active iron and bacterial growth in serum of haemodialysis patients after iv. iron-saccharate administration[J].Nephrol Dial Transplant, 2000, 15(11):1827-34 [55]LITTON E, XIAO J, HO K M.Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials.[J].Bmj, 2013, 347(f4):8-22 [56]KORTMAN G A M, REIJNDERS D, SWINKELS D W.Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.[J].Hemodial Int, 2017, 21( Suppl 1):28-36 [57]RIBEIRO M, FONSECA L, ANJOS J S, et al.Oral iron supplementation in patients with chronic kidney disease: Can it be harmful to the gut microbiota?[J].Nutr Clin Pract, 2022, 37(1):81-93 [58]KRELA-KA?MIERCZAK I, CZARNYWOJTEK A, SKORACKA K, et al.Is There an Ideal Diet to Protect against Iodine Deficiency?[J].Nutrients, 2021, 13(2):5-13 [59]BOUGA M, LEAN M E J, COMBET E.Contemporary challenges to iodine status and nutrition: the role of foods,dietary recommendations,fortification and supplementation[J].Proc Nutr Soc, 2018, 77(3):302-13 [60]NATH S K, MOINIER B, THUILLIER F, et al.Urinary excretion of iodide and fluoride from supplemented food grade salt[J].Int J Vitam Nutr Res, 1992, 62(1):66-72 [61]LIM V S.Thyroid function in patients with chronic renal failure[J].Am J Kidney Dis, 2001, 38(4 Suppl 1):S80-4 [62]MARKOU K, GEORGOPOULOS N, KYRIAZOPOULOU V, et al.Iodine-Induced hypothyroidism[J].Thyroid, 2001, 11(5):501-10 [63]TAKEDA S, MICHIGISHI T, TAKAZAKURA E.Iodine-induced hypothyroidism in patients on regular dialysis treatment[J].Nephron, 1993, 65(1):51-5
文章导航

/

[an error occurred while processing this directive]